直肠间隔物相关急性毒性——403例前列腺癌患者植入凝胶或球囊间隔物后的内镜检查结果
研究纳入403例接受直肠间隔物(球囊264例、凝胶139例)的前列腺癌患者,非随机分组,分别接受常规分割或中度大分割放疗。前瞻性采用维也纳直肠镜评分和CTCAE V.4评估毒性,总体直肠毒性很低,但急性3级毒性(直肠穿孔和尿道损伤)发生率为1.49%(n=6),且仅见于球囊间隔物组。
要点
- 403例患者中球囊间隔物264例、凝胶间隔物139例,分组为非随机。
- 急性3级毒性(直肠穿孔和尿道损伤)发生率为1.49%(n=6),仅见于球囊间隔物组。
- 植入后MR影像分析未发现球囊位置异常或旋转不良是间隔物相关3级毒性的预测因素。
核心结论
- 间隔物技术是减少前直肠壁剂量的有效手段,但剂量 sparing 的获益需与直肠穿孔等低概率并发症风险权衡。
研究设计与样本
- 共403例前列腺癌患者接受直肠间隔物植入,其中球囊264例、凝胶139例,分组为非随机。
- 276例接受常规分割放疗,其余125例接受中度大分割放疗。
- 采用维也纳直肠镜评分和CTCAE V.4前瞻性评估间隔物相关急性和晚期直肠毒性;对球囊亚组另在植入后计划MR影像上回顾性分析球囊位置和旋转与直肠反应发生率及分级的相关性。
主要发现
- 总体直肠毒性很低,平均维也纳直肠镜评分在植入后第1天为0.06,放疗结束时为0.10,6个月随访时为0.31,12个月随访时为0.42。
- 与植入操作直接相关的急性3级毒性(直肠穿孔和尿道损伤)发生率为1.49%(n=6),且仅见于接受球囊间隔物的患者。
- 植入后MR影像分析未发现球囊位置异常或旋转不良是间隔物相关3级毒性发生的预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rectal spacers are used to limit dose to the anterior rectal wall in high dose external beam radiation therapy of the prostate and have been shown to reduce radiation induced toxicity. Here we report the complication rate and toxicity of the implantation procedure in a large cohort of patients who have either received a gel- or balloon-type spacer. METHODS: In total, 403 patients received rectal spacing, 264 with balloon, 139 with gel. Allocation was non-randomized. Two hundred seventy-six patients were treated with normofractionated regimen, the remaining 125 patients in moderate hypofractionation. Spacer related acute and late rectal toxicity was prospectively assessed by endoscopy using a mucosa scoring system (Vienna Rectoscopy Score) as well as CTCAE V.4. For the balloon subgroup, position and rotation of balloon spacers were additionally correlated to incidence and grade of rectal reactions in a post-hoc analysis of post-implant planning MRIs. RESULTS: Overall rectal toxicity was very low with average VRS scores of 0.06 at the day after implantation, 0.10 at the end of RT, 0.31 at 6 months and 0.42 at 12 months follow up. Acute Grade 3 toxicity (rectum perforation and urethral damage) directly related to the implantation procedure occurred in 1.49% (n = 6) and was seen exclusively in patients who had received the spacer balloon. Analysis of post implant MR imaging did not identify abnormal or mal-rotated positions of this spacer to be a predictive factors for the occurrence of spacer related G3 toxicities. CONCLUSIONS: Spacer technology is an effective means to minimize dose to the anterior rectal wall. However, the benefits in terms of dose sparing need to be weighed against the low, but possible risks of complications such as rectum perforation.
引用
- Schörghofer A, Drerup M, Kunit T, et al. Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers. Radiat Oncol. 2019. PMID: 30876433. doi:10.1186/s13014-019-1248-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。